Bionano Genomics (BNGO) Return on Capital Employed (2018 - 2026)

Bionano Genomics (BNGO) has 9 years of Return on Capital Employed data on file, last reported at 68.32% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 9072.0% year-over-year to 68.32%; the trailing twelve-month figure through Mar 2026 stood at 68.32% (up 9072.0% YoY), and the FY2025 full-year result was 63.89%, up 3222.0% from the prior year.
• Return on Capital Employed fell to 68.32% in Q1 2026, from 62.45% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 27.87% in Q1 2022 to a low of 232.77% in Q4 2024.
• A 5-year average of 107.47% and a median of 68.32% in 2026 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed plunged 17227 bps in 2023 and surged 17032 bps in 2025, its largest moves.
• Tracing BNGO's Return on Capital Employed over 5 years: stood at 47.08% in 2022, then plunged by 366 bps to 219.36% in 2023, then dropped by 6 bps to 232.77% in 2024, then surged by 73 bps to 62.45% in 2025, then dropped by 9 bps to 68.32% in 2026.
• Business Quant data shows BNGO's Return on Capital Employed at 68.32% in Q1 2026, 62.45% in Q4 2025, and 67.35% in Q3 2025.